Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1856 1
1869 1
1908 1
1923 1
1928 1
1930 1
1931 1
1936 2
1937 2
1944 1
1945 25
1946 111
1947 128
1948 194
1949 165
1950 267
1951 376
1952 376
1953 425
1954 385
1955 412
1956 389
1957 396
1958 361
1959 395
1960 416
1961 514
1962 546
1963 890
1964 1161
1965 942
1966 965
1967 1107
1968 1222
1969 1292
1970 1158
1971 1306
1972 1406
1973 1338
1974 1381
1975 1468
1976 1595
1977 1639
1978 1756
1979 1806
1980 1824
1981 1931
1982 2038
1983 2234
1984 2328
1985 2429
1986 2351
1987 2459
1988 2335
1989 2614
1990 2778
1991 2651
1992 2846
1993 2879
1994 3118
1995 3236
1996 3221
1997 3347
1998 3338
1999 3631
2000 3692
2001 3865
2002 3730
2003 4029
2004 4292
2005 4701
2006 4900
2007 5119
2008 5597
2009 6086
2010 6781
2011 7377
2012 7932
2013 8412
2014 9513
2015 10129
2016 10376
2017 10845
2018 11388
2019 11725
2020 10038
2021 914
Text availability
Article attribute
Article type
Publication date

Search Results

216,367 results
Results by year
Filters applied: . Clear all
Page 1
Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
Tang W , Fan W , Lau J , Deng L , Shen Z , Chen X . Tang W , et al. Chem Soc Rev. 2019 Jun 4;48(11):2967-3014. doi: 10.1039/c8cs00805a. Chem Soc Rev. 2019. PMID: 31089607 Review.
Brain cancer, especially the most common type of glioblastoma, is highly invasive and known as one of the most devastating and deadly neoplasms. Despite surgical and medical advances, the prognosis for most brain cancer patients remains dismal a
Brain cancer, especially the most common type of glioblastoma, is highly invasive and known as one of the most devastating and
Glycosylation Changes in Brain Cancer.
Veillon L, Fakih C, Abou-El-Hassan H, Kobeissy F, Mechref Y. Veillon L, et al. ACS Chem Neurosci. 2018 Jan 17;9(1):51-72. doi: 10.1021/acschemneuro.7b00271. Epub 2017 Nov 7. ACS Chem Neurosci. 2018. PMID: 28982002 Free PMC article. Review.
The focus of this Review is the discussion of aberrant glycosylation related to brain cancer. Altered sialylation and fucosylation of N- and O-glycans play a role in the development and progression of brain cancer. Additionally, aberrant O-glycan expre …
The focus of this Review is the discussion of aberrant glycosylation related to brain cancer. Altered sialylation and fucosyla …
Brain Cancer: Implication to Disease, Therapeutic Strategies and Tumor Targeted Drug Delivery Approaches.
Shah V, Kochar P. Shah V, et al. Recent Pat Anticancer Drug Discov. 2018;13(1):70-85. doi: 10.2174/1574892812666171129142023. Recent Pat Anticancer Drug Discov. 2018. PMID: 29189177 Review.
Brain cancer is identified as one of the most formidable forms of cancer due to several hurdles posed by the anatomy and physiology of the brain on the therapeutic strategies employed for treating brain cancer. ...METHODS: Conventional su
Brain cancer is identified as one of the most formidable forms of cancer due to several hurdles posed by the anatomy an
The Gut-Brain Axis, Paving the Way to Brain Cancer.
Mehrian-Shai R, Reichardt JKV, Harris CC, Toren A. Mehrian-Shai R, et al. Trends Cancer. 2019 Apr;5(4):200-207. doi: 10.1016/j.trecan.2019.02.008. Epub 2019 Mar 16. Trends Cancer. 2019. PMID: 30961828 Free PMC article. Review.
The gut-brain axis formed by blood and lymphatic vessels paves the way for microbiota to impact the brain. ...We propose here a novel gear model connecting these complex interdisciplinary fields. Our model may impact mechanistic studies of brain cancer
The gut-brain axis formed by blood and lymphatic vessels paves the way for microbiota to impact the brain. ...We propose here …
DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas.
Kaina B, Christmann M. Kaina B, et al. DNA Repair (Amst). 2019 Jun;78:128-141. doi: 10.1016/j.dnarep.2019.04.007. Epub 2019 Apr 15. DNA Repair (Amst). 2019. PMID: 31039537 Review.
Alkylating agents have been used since the 60ties in brain cancer chemotherapy. Their target is the DNA and, although the DNA of normal and cancer cells is damaged unselectively, they exert tumor-specific killing effects because of downregulation of some DNA …
Alkylating agents have been used since the 60ties in brain cancer chemotherapy. Their target is the DNA and, although the DNA …
Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, Yin VP, Lockman P, Bai S. Yang T, et al. Pharm Res. 2015 Jun;32(6):2003-14. doi: 10.1007/s11095-014-1593-y. Epub 2015 Jan 22. Pharm Res. 2015. PMID: 25609010 Free PMC article.
In the brain cancer model, exosome delivered anticancer drugs significantly decreased fluorescent intensity of xenotransplanted cancer cells and tumor growth marker. CONCLUSIONS: Brain endothelial cell derived exosomes could be potentially used as a ca …
In the brain cancer model, exosome delivered anticancer drugs significantly decreased fluorescent intensity of xenotransplante …
Searching for the roots of brain cancer.
Savage N. Savage N. Nature. 2018 Sep;561(7724):S50-S51. doi: 10.1038/d41586-018-06709-2. Nature. 2018. PMID: 30258163 No abstract available.
Brain metastases.
Gállego Pérez-Larraya J, Hildebrand J. Gállego Pérez-Larraya J, et al. Handb Clin Neurol. 2014;121:1143-57. doi: 10.1016/B978-0-7020-4088-7.00077-8. Handb Clin Neurol. 2014. PMID: 24365409 Review.
Brain metastases are the most frequent neurological complication of cancer and the most common brain tumour type. ...Brain metastases are best demonstrated by MRI, which is sensitive but non-specific. ...
Brain metastases are the most frequent neurological complication of cancer and the most common brain tumour type. ...
Microenvironmental Heterogeneity in Brain Malignancies.
Perus LJM, Walsh LA. Perus LJM, et al. Front Immunol. 2019 Oct 1;10:2294. doi: 10.3389/fimmu.2019.02294. eCollection 2019. Front Immunol. 2019. PMID: 31632393 Free PMC article. Review.
Brain tumors are among the deadliest malignancies. The brain tumor microenvironment (TME) hosts a unique collection of cells, soluble factors, and extracellular matrix components that regulate disease evolution of both primary and metastatic brain malignancie
Brain tumors are among the deadliest malignancies. The brain tumor microenvironment (TME) hosts a unique collection of cells,
Brain Cancer Triage Test Advances.
Abbasi J. Abbasi J. JAMA. 2019 Dec 10;322(22):2161. doi: 10.1001/jama.2019.19882. JAMA. 2019. PMID: 31821416 No abstract available.
216,367 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page